Conversations about innovation happen constantly, yet execution rarely receives the same attention.
Breakthrough research can capture headlines, attract investment, and signal scientific progress, yet discovery alone rarely builds industries or creates lasting economic growth. The hard work continues after the breakthrough, when ideas must leave the laboratory and prove themselves in the real world.
Researchers must think commercially, founders must navigate capital and regulation, and investors must recognize disciplined opportunity rather than unmanaged risk. When those elements come together, ideas move beyond the laboratory and begin to shape markets and improve lives.
Much of my work has centered on that transition from discovery to execution. Over the past five decades, I’ve worked alongside entrepreneurs, investors, and leadership teams building companies in highly competitive markets. Extraordinary breakthroughs emerge from scientific institutions every day, yet lasting impact depends on whether those discoveries become durable companies capable of competing globally.
At BioHealth Innovation, our work centers on helping innovators navigate that journey from discovery to commercialization. Researchers often understand their science deeply, but building a company requires an entirely different set of capabilities. Founders must approach capital strategically, manage regulatory pathways, and assemble leadership teams capable of translating science into viable products and services. That focus guides everything we do.
Building the Innovation Ecosystem
Over the course of my career, one lesson has remained clear: innovation accelerates when ecosystems move together.
Few regions hold the advantages Maryland does. Federal research agencies operate alongside world-class academic institutions and a rapidly expanding life sciences industry. Breakthrough discoveries continue to emerge across the region every day. Turning those discoveries into successful companies demands coordination across the entire innovation environment.
Progress depends on collaboration among government agencies, universities, nonprofit organizations, industry leaders, and investors. Connecting those groups creates the support structure entrepreneurs need as they move from early discovery toward commercialization and growth.
When those partnerships strengthen, entrepreneurs gain access to mentorship, capital, and infrastructure at the moments they need them most. Alignment across the biohealth ecosystem transforms promising research into scalable businesses capable of competing globally.
A Vision for Maryland
The opportunity for Maryland reaches far beyond discovery: extraordinary research happens every day, hopefully leading to commercial services and products.
At BioHealth Innovation, I focus on helping founders move breakthrough science out of laboratories and into the marketplace. Entrepreneurs gain access to mentorship, capital networks, and the strategic guidance required to build companies that can survive, grow, and compete globally.
That work depends on strong teams and shared success. Throughout my career, mentors reinforced lessons that continue to guide how I lead. Surround yourself with people whose strengths expand your own. Share success with those who help create it. Stay grounded in purpose while pursuing growth.
Every day, I work alongside entrepreneurs determined to transform discovery into real companies. Maryland already leads in scientific discovery. The next chapter will be written by the companies we build.
